Compare

Axogen, Inc. vs InMode Ltd. vs Outset Medical, Inc. vs Ceribell, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearAxogen, Inc.
AXGN
InMode Ltd.
INMD
Outset Medical, Inc.
OM
Ceribell, Inc.
CBLL
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$225.21M$370.50M$119.48M$89.06M
Revenue growth (YoY)+20.2%-6.2%+5.1%+36.1%
Gross margin74.3%78.5%39.1%87.9%
Operating margin-3.5%23.0%-55.8%-65.6%
Net margin-7.0%25.3%-68.3%-60.0%
Net income-$15.70M$93.83M-$81.65M-$53.41M
EPS (Diluted)-$0.34$1.43-$5.37-$1.46
Operating cash flow$812.0K$85.26M-$46.33M-$40.81M
Free cash flow-$2.93M$84.28M-$47.12M-$41.58M
Cash & equivalents$35.55M$302.54M$35.01M$40.48M
Total assets$221.69M$766.43M$264.50M$195.80M
Total liabilities$92.84M$83.23M$137.54M$40.47M
Shareholders' equity$128.85M$683.20M$126.95M$155.34M
Return on year-end equity-12.2%13.7%-64.3%-34.4%
Shares outstanding47.20M63.36M18.17M37.49M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearAxogen, Inc.InMode Ltd.Outset Medical, Inc.Ceribell, Inc.
Latest$225.21M
Ended 2025-12-31
$370.50M
Ended 2025-12-31
$119.48M
Ended 2025-12-31
$89.06M
Ended 2025-12-31
1 year earlier$187.34M
Ended 2024-12-31
$394.82M
Ended 2024-12-31
$113.69M
Ended 2024-12-31
$65.44M
Ended 2024-12-31
2 years earlier$159.01M
Ended 2023-12-31
$492.05M
Ended 2023-12-31
$130.38M
Ended 2023-12-31
$45.23M
Ended 2023-12-31
3 years earlier$138.58M
Ended 2022-12-31
$454.27M
Ended 2022-12-31
$115.38M
Ended 2022-12-31
n/a
4 years earlier$127.36M
Ended 2021-12-31
$357.56M
Ended 2021-12-31
$102.60M
Ended 2021-12-31
n/a